Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
11.88 USD | -0.08 USD | -0.67 % |
---|
Vortag | 11.96 USD | Datum | 11.12.2024 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Stellar ETP | CH1109575535 | 373.37% | |
21Shares Ripple XRP ETP | CH0454664043 | 362.53% | |
21Shares Sui Staking ETP | CH1360612159 | 316.59% | |
21Shares Algorand ETP | CH1146882316 | 271.70% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Cardano ETP | CH1102728750 | 227.67% | |
21Shares Injective Staking ETP | CH1360612134 | 52.37% | |
21Shares Immutable ETP | CH1360612142 | 28.89% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 401.14% | |
21Shares Stellar ETP | CH1109575535 | 344.33% | |
21Shares Aave ETP | CH1135202120 | 230.68% | |
21Shares Algorand ETP | CH1146882316 | 186.41% | |
21Shares Cardano ETP | CH1102728750 | 154.07% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 285.63% | |
21Shares Stellar ETP | CH1109575535 | 242.86% | |
21Shares Solana staking ETP | CH1114873776 | 236.97% | |
21Shares Fantom ETP | CH1168929078 | 229.54% | |
21Shares Aave ETP | CH1135202120 | 213.78% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 1’610.00% | |
21Shares Ripple XRP ETP | CH0454664043 | 503.47% | |
21Shares Bitcoin Core ETP | CH1199067674 | 482.21% | |
21Shares Bitcoin ETP | CH0454664001 | 467.48% | |
21Shares Fantom ETP | CH1168929078 | 387.27% |
Fundamentaldaten
Valor | |
ISIN | IE000XWBFHZ3 |
Emittent | Janus Henderson Investors |
Aufgelegt in | Ireland |
Auflagedatum | 02.08.2022 |
Kategorie | Branchen: Gesundheitswesen |
Währung | USD |
Volumen | 3’603’302’532.86 |
Depotbank | J.P. Morgan SE, Dublin Branch |
Geschäftsjahresende | 31.12. |
Berichtsstand | 28.08.2024 |
Anlagepolitik
So investiert der Janus Henderson Capital Funds plc - Global Life Sciences Fund Class T2 USD Fonds: Der Fonds strebt langzeitliches Kapitalwachstum an. Dies wird durch Investitionen in Aktienwertpapiere weltweiter Firmen mit gutem Wachstumspotential erreicht.
ETP Performance: Janus Henderson Capital Funds plc - Global Life Sciences Fund Class T2 USD Fonds
Performance 1 Jahr | 11.86 | |
Performance 2 Jahre | 10.92 | |
Performance 3 Jahre | - | |
Performance 5 Jahre | - | |
Performance 10 Jahre | - |